Preferential in vivo action of F15599, a novel 5‐HT1Areceptor agonist, at postsynaptic 5‐HT1Areceptors
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background and purpose: F15599, a novel 5‐hydroxytryptamine (5‐HT)1A receptor agonist with 1000‐fold selectivity for 5‐HT compared with other monoamine receptors, shows antidepressant and procognitive activity at very low doses in animal models. We examined the in vivo activity of F15599 at somatodendritic autoreceptors and postsynaptic 5‐HT 1A heteroreceptors. Experimental approach: In vivo single unit and local field potential recordings and microdialysis in the rat. Key results: F15599 increased the discharge rate of pyramidal neurones in medial prefrontal cortex (mPFC) from 0.2 µg·kg−1 i.v and reduced that of dorsal raphe 5‐hydroxytryptaminergic neurones at doses >10‐fold higher (minimal effective dose 8.2 µg·kg−1 i.v.). Both effects were reversed by the 5‐HT 1A antagonist (±)WAY100635. F15599 did not alter low frequency oscillations (∼1 Hz) in mPFC. In microdialysis studies, F15599 increased dopamine output in mPFC (an effect dependent on the activation of postsynaptic 5‐HT 1A receptors) with an ED 50 of 30 µg·kg−1 i.p., whereas it reduced hippocampal 5‐HT release (an effect dependent exclusively on 5‐HT 1A autoreceptor activation) with an ED 50 of 240 µg·kg−1 i.p. Likewise, application of F15599 by reverse dialysis in mPFC increased dopamine output in a concentration‐dependent manner. All neurochemical responses to F15599 were prevented by administration of (±)WAY100635. Conclusions and implications: These results indicate that systemic administration of F15599 preferentially activates postsynaptic 5‐HT 1A receptors in PFC rather than somatodendritic 5‐HT 1A autoreceptors. This regional selectivity distinguishes F15599 from previously developed 5‐HT 1A receptor agonists, which preferentially activate somatodendritic 5‐HT 1A autoreceptors, suggesting that F15599 may be particularly useful in the treatment of depression and of cognitive deficits in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thalamocortical oscillations in the sleeping and aroused brain
Steriade, M., McCormick, D. A., & Sejnowski, T. J. (1993) · Science · doi:10.1126/science.8235588 · Cited by 3,564 · cited 2×
“3–4 Hz) oscillations recorded extracellularly in anaesthetized animals are similar to the physiological changes in cortical activity during slow-wave sleep (Steriade et al., 1993).”
InfluentialBoosting slow oscillations during sleep potentiates memory
Marshall, L., Helgadóttir, H., Mölle, M., & Born, J. (2006) · Nature · doi:10.1038/nature05278 · Cited by 1,792
Cellular and network mechanisms of rhythmic recurrent activity in neocortex
Sanchez-Vives, M. V., & McCormick, D. A. (2000) · Nature Neuroscience · doi:10.1038/79848 · Cited by 1,539
Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231 · cited 2×
“Likewise, differences in the composition and response of NMDA receptor subtypes have been shown (Hollmann and Heinemann, 1994; Plant et al., 1997) and a differential response of pyramidal and GABAergic neurones in mPFC to MK-801 have been reported (Homayoun and Moghaddam, 2007).”
BackgroundJonas, P. (1994) · Neuron · doi:10.1016/0896-6273(94)90444-8 · Cited by 666 · cited 1×
“Although this possibility requires further testing, it is supported by the existence of molecular and functional differences between neurotransmitter receptors expressed by GABAergic and glutamatergic cells (Jonas et al., 1994).”
BackgroundCelada, P., Puig, M. V., Casanovas, J. M., Guillazo, G., & Artigas, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09917.2001 · Cited by 497 · cited 3×
“For 5-hydroxytryptaminergic neurones, recordings were made as described in Celada et al. (2001) and Romero et al. (2003).”
BackgroundMethodSelf-citationSantana, N. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh070 · Cited by 486 · cited 2×
“…and limbic system (Pazos and Palacios, 1985; Pompeiano et al., 1992; Kia et al., 1996; Riad et al., 2000; Martinez et al., 2001; Cruz et al., 2004; Santana et al., 2004), where they mediate inhibitory actions of 5-HT (Andrade and Nicoll, 1987; Blier and de Montigny, 1987; Innis and Aghajanian,…”
BackgroundAmargos-Bosch, M. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhg128 · Cited by 370
Cited by
Serotonin modulation of cortical neurons and networks
Celada, P., Puig, M. V., & Artigas, F. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00025 · Cited by 462
Self-citationAlbert, P. R., Vahid-Ansari, F., & Luckhart, C. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00199 · Cited by 321
Celada, P., Bortolozzi, A., & Artigas, F. (2013) · CNS Drugs · doi:10.1007/s40263-013-0071-0 · Cited by 323
“5-HT1A-R agonists also increase PFC dopamine release by activating local 5-HT1A-Rs and increasing the activity of mesocortical dopamine neurons [41, 64] (Fig.”
Self-citationSerotonin receptors involved in antidepressant effects
Artigas, F. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.006 · Cited by 311
Self-citationBarnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., et al. (2021) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 263
Self-citation
Metadata
- Authors
- Lladó‐Pelfort, L., Assié, M., Newman‐Tancredi, A., Artigas, F., & Celada, P.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2010-03-08
- Volume
- 160
- Issue
- 8
- Pages
- 1929-1940
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1588173517
- Cited by
- 103
- References
- 8
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Preferential in vivo action of F15599, a novel 5‐HT1Areceptor agonist, at postsynaptic 5‐HT1Areceptors. https://app.cochat.ai/papers/10.1111/j.1476-5381.2010.00738.x
- The paper
- Lladó‐Pelfort, L., Assié, M., Newman‐Tancredi, A., Artigas, F., & Celada, P. (2010). Preferential in vivo action of F15599, a novel 5‐HT1Areceptor agonist, at postsynaptic 5‐HT1Areceptors. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2010.00738.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.